申请人:——
公开号:US20040006066A1
公开(公告)日:2004-01-08
This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II:
1
wherein Ar is optionally substituted aryl or heteroaryl, R
1
-R
4
are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts thereof. The invention further relates to processes for preparing such compounds, to pharmaceutical compositions containing such compounds, and to methods for their use as therapeutic agents.
这项发明涉及一般为CRF-1受体拮抗剂的化合物,其由式I或式II表示:其中Ar是可选择取代的芳基或杂环芳基,R1-R4如规范中定义;或其各个异构体、消旋或非消旋异构体混合物,或其药学上可接受的盐。该发明还涉及制备这种化合物的方法,含有这种化合物的药物组合物,以及它们作为治疗剂的使用方法。